| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 3,029,207 | 2,824,141 | 3,225,264 | 3,270,597 | | Cost of Revenue | 2,169,084 | 2,060,093 | 2,315,002 | 2,441,475 | | | Gross Profit | 860,123 | 764,048 | 910,262 | 829,122 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 892,919 | 861,977 | 970,719 | 993,011 | | Non Recurring |
-
|
-
|
-
| 1,484,964 | | Others |
-
|
-
|
-
| 5,619 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (32,796) | (97,929) | (60,457) | (1,654,472) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,393 | 1,130 | (2,365) | 8,810 | | Earnings Before Interest And Taxes | (23,403) | (96,799) | (62,822) | (1,645,662) | | Interest Expense | 17,242 | 16,745 | 17,918 | 22,655 | | Income Before Tax | (40,645) | (113,544) | (80,740) | (1,668,317) | | Income Tax Expense | 358,400 | (30,680) | (25,408) | (129,306) | | Minority Interest | 1,011 | 792 | 593 |
-
| | | | Net Income From Continuing Ops | (398,034) | (82,072) | (54,739) | (1,539,011) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (398,034) | (82,072) | (54,739) | (1,539,011) | | Preferred Stock And Other Adjustments | (14,931) | (486) |
-
|
-
| | | Net Income Applicable To Common Shares | ($412,965) | ($82,558) | ($54,739) | ($1,539,011) |
|
0.31% Nasdaq 0.00%
Income Statement
